203 related articles for article (PubMed ID: 12807245)
1. Microvessel density (MVD) as a prognosticator in endometrial carcinoma.
Ozalp S; Yalcin OT; Acikalin M; Tanir HM; Oner U; Akkoyunlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):305-8. PubMed ID: 12807245
[TBL] [Abstract][Full Text] [Related]
2. Parametrial spread is a prognostic factor in endometrial carcinoma.
Sato R; Jobo T; Kuramoto H
Eur J Gynaecol Oncol; 2003; 24(3-4):241-5. PubMed ID: 12807232
[TBL] [Abstract][Full Text] [Related]
3. p53 overexpression as a prognostic indicator in endometrial carcinoma.
Ozalp S; Yalcin OT; Tanir HM; Kabukcuoglu S; Erol G
Eur J Gynaecol Oncol; 2003; 24(3-4):275-8. PubMed ID: 12807239
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in endometrial carcinoma.
Kaku T; Kamura T; Kinukawa N; Kobayashi H; Sakai K; Tsuruchi N; Saito T; Kawauchi S; Tsuneyoshi M; Nakano H
Cancer; 1997 Aug; 80(4):741-7. PubMed ID: 9264358
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in endometrial carcinoma: correlation with survival and clinicopathologic risk factors.
Ozuysal S; Bilgin T; Ozan H; Kara HF; Oztürk H; Ercan I
Gynecol Obstet Invest; 2003; 55(3):173-7. PubMed ID: 12865598
[TBL] [Abstract][Full Text] [Related]
7. The value of ultrasonography in preoperative assessment of selected prognostic factors in endometrial cancer.
Sawicki W; Spiewankiewicz B; Stelmachów J; Cendrowski K
Eur J Gynaecol Oncol; 2003; 24(3-4):293-8. PubMed ID: 12807243
[TBL] [Abstract][Full Text] [Related]
8. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
9. Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients.
Zhang C; Havrilesky LJ; Broadwater G; Di Santo N; Ehrisman JA; Lee PS; Berchuck A; Alvarez Secord A; Bean S; Bentley RC; Valea FA
Gynecol Oncol; 2014 May; 133(2):211-5. PubMed ID: 24582867
[TBL] [Abstract][Full Text] [Related]
10. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
11. [Significance of proliferating cell nuclear antigen (PCNA) index and microvessel density (MVD) in endometrial carcinoma].
Xiao L; Tang LD
Ai Zheng; 2005 Jan; 24(1):19-22. PubMed ID: 15642194
[TBL] [Abstract][Full Text] [Related]
12. [Clinical implications of positive peritoneal cytology in endometrial cancer].
Ren YL; Wang HY; Shan BE; Ping B; Shi DR
Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
[TBL] [Abstract][Full Text] [Related]
13. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.
Vaizoglu F; Yuce K; Salman MC; Basaran D; Calis P; Ozgul N; Usubutun A
Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931
[TBL] [Abstract][Full Text] [Related]
14. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
[TBL] [Abstract][Full Text] [Related]
15. Endometrioid adenocarcinoma of the uterus: surgico-pathological correlations and role of pelvic lymphadenectomy.
Chee JJ; Ho TH; Tay EH; Low JJ; Yam KL
Ann Acad Med Singap; 2003 Sep; 32(5):670-5. PubMed ID: 14626800
[TBL] [Abstract][Full Text] [Related]
16. CD105 expression is an independent predictor of survival in patients with endometrial cancer.
Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O
Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456
[TBL] [Abstract][Full Text] [Related]
17. The Value of Intratumoral and Extratumoral Microvessel Density for the Tumor-dominated Area in the Endometrial Carcinoma.
Kilinç E; Bahar AY
Appl Immunohistochem Mol Morphol; 2022 Aug; 30(7):501-508. PubMed ID: 35731561
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for pelvic lymph node metastasis in endometrial cancer.
Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
[TBL] [Abstract][Full Text] [Related]
19. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
20. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.
Baser E; Togrul C; Ozgu E; Ayhan S; Caglar M; Erkaya S; Gungor T
Asian Pac J Cancer Prev; 2013; 14(12):7635-8. PubMed ID: 24460345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
